Chronic opioid use is a common but underappreciated cause of androgen deficiency in men, with prevalence varying between 20% and 80%, and limited clinical trial data suggest testosterone therapy improves libido, body composition, and quality of life while early evidence indicates anti-nociceptive properties.
Key Findings
Results
The prevalence of opioid-induced androgen deficiency in men varies widely between 20% and 80%.
Prevalence is influenced by the type of opioid used, duration of exposure, age of the cohort, and how low testosterone was defined.
Despite its high prevalence, this adverse effect of chronic opioid use remains underappreciated by clinicians.
As a result, androgen deficiency remains underdiagnosed and likely undertreated.
Literature reviewed spanned from 1950 through June 2024.
Results
Opioids suppress the gonadal axis primarily by inhibiting GnRH synthesis and secretion.
The mechanism is described as inhibition of gonadotropin-releasing hormone (GnRH) synthesis and secretion.
This represents a central (hypothalamic) mechanism of androgen suppression.
The resulting condition is classified as opioid-induced androgen deficiency.
Results
Testosterone therapy in men with opioid-induced androgen deficiency improves libido, body composition, and certain domains of quality of life.
These findings are based on 'limited data from clinical trials.'
The review characterizes the available clinical trial evidence as limited.
Testosterone therapy could be considered in men with 'unequivocal androgen deficiency after a thorough clinical evaluation.'
Results
Early evidence suggests that testosterone has anti-nociceptive properties in men with opioid-induced androgen deficiency.
This finding is described as 'early evidence' from clinical studies.
The anti-nociceptive properties of testosterone confirm findings from preclinical and population studies.
Ongoing clinical trials are expected to shed further light on the efficacy of testosterone therapy, particularly regarding its anti-nociceptive effects.
Anti-nociceptive effects of testosterone were identified as a particular focus of the review.
Conclusions
There is a recognized need to raise awareness among clinicians regarding opioid-induced androgen deficiency as an adverse effect of opioid use.
Opioid analgesics are frequently prescribed for the treatment of chronic pain.
The adverse effect of androgen deficiency 'remains underappreciated by clinicians.'
The condition is described as 'a common but underappreciated cause of androgen deficiency in men.'
Key search terms used were 'opioids,' 'hypogonadism,' 'low testosterone,' and 'testosterone therapy,' with sources from PubMed and references within retrieved publications.
Kafel H, Braga-Basaria M, Basaria S. (2025). Opioid-induced androgen deficiency in men: Prevalence, pathophysiology, and efficacy of testosterone therapy.. Andrology. https://doi.org/10.1111/andr.70013